You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ANTIVERT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ANTIVERT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00641797 ↗ Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients Completed Lehigh Valley Hospital N/A 2006-11-01 Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.
NCT01443858 ↗ Meclizine as a Potential Smoking Cessation Treatment Completed Philip Morris USA, Inc. Phase 2 2011-08-01 The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
NCT01443858 ↗ Meclizine as a Potential Smoking Cessation Treatment Completed Duke University Phase 2 2011-08-01 The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ANTIVERT

Condition Name

Condition Name for ANTIVERT
Intervention Trials
Benign Paroxysmal Positional Vertigo 1
Smoking Cessation 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ANTIVERT
Intervention Trials
Vertigo 1
Dizziness 1
Benign Paroxysmal Positional Vertigo 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ANTIVERT

Trials by Country

Trials by Country for ANTIVERT
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ANTIVERT
Location Trials
North Carolina 1
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ANTIVERT

Clinical Trial Phase

Clinical Trial Phase for ANTIVERT
Clinical Trial Phase Trials
Phase 2 1
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ANTIVERT
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ANTIVERT

Sponsor Name

Sponsor Name for ANTIVERT
Sponsor Trials
Lehigh Valley Hospital 1
Philip Morris USA, Inc. 1
Duke University 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ANTIVERT
Sponsor Trials
Other 2
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.